Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
- 8 October 2008
- reference entry
- Published by Wiley
- No. 4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- LUTS treatment: Future treatment optionsNeurourology and Urodynamics, 2007
- Comparison of two α 1 ‐adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover studyBJU International, 2006
- Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patientsThe Prostate, 2006
- Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trialBJU International, 2005
- Empirical Evidence of BiasJAMA, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986